HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency.

Abstract
Coenzyme Q10 (CoQ10) deficiency (MIM 607426) causes a mitochondrial syndrome with variability in the clinical presentations. Patients with CoQ10 deficiency show inconsistent responses to oral ubiquinone-10 supplementation, with the highest percentage of unsuccessful results in patients with neurological symptoms (encephalopathy, cerebellar ataxia or multisystemic disease). Failure in the ubiquinone-10 treatment may be the result of its poor absorption and bioavailability, which may be improved by using different pharmacological formulations. In a mouse model (Coq9(X/X)) of mitochondrial encephalopathy due to CoQ deficiency, we have evaluated oral supplementation with water-soluble formulations of reduced (ubiquinol-10) and oxidized (ubiquinone-10) forms of CoQ10. Our results show that CoQ10 was increased in all tissues after supplementation with ubiquinone-10 or ubiquinol-10, with the tissue levels of CoQ10 with ubiquinol-10 being higher than with ubiquinone-10. Moreover, only ubiquinol-10 was able to increase the levels of CoQ10 in mitochondria from cerebrum of Coq9(X/X) mice. Consequently, ubiquinol-10 was more efficient than ubiquinone-10 in increasing the animal body weight and CoQ-dependent respiratory chain complex activities, and reducing the vacuolization, astrogliosis and oxidative damage in diencephalon, septum-striatum and, to a lesser extent, in brainstem. These results suggest that water-soluble formulations of ubiquinol-10 may improve the efficacy of CoQ10 therapy in primary and secondary CoQ10 deficiencies, other mitochondrial diseases and neurodegenerative diseases.
AuthorsLaura García-Corzo, Marta Luna-Sánchez, Carolina Doerrier, Francisco Ortiz, Germaine Escames, Darío Acuña-Castroviejo, Luis C López
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1842 Issue 7 Pg. 893-901 (Jul 2014) ISSN: 0006-3002 [Print] Netherlands
PMID24576561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Ubiquinone
  • ubiquinol-10
  • Ubiquinone Q2
Topics
  • Animals
  • Ataxia (drug therapy)
  • Brain Diseases (drug therapy)
  • Brain Stem (drug effects)
  • Corpus Striatum (drug effects)
  • Electron Transport (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria (drug effects)
  • Mitochondrial Diseases (drug therapy)
  • Mitochondrial Encephalomyopathies (drug therapy)
  • Muscle Weakness (drug therapy)
  • Oxidative Stress (drug effects)
  • Ubiquinone (analogs & derivatives, deficiency, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: